Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term Safety of Ba253BINEB in COPD
NCT02182635Phase 3Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Aug 1998
- Primary completion
- Mar 1999
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of oxitropium bromide in chronic obstructive pulmonary disease (COPD), sponsored by Boehringer Ingelheim. Started Aug 1998; status: completed.
02
Drugs
oxitropium bromide
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT02182635.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02182635.